CFIMX
Price
$138.05
Change
-$0.00 (-0.00%)
Updated
Sep 6 closing price
FXAIX
Price
$188.25
Change
-$0.00 (-0.00%)
Updated
Sep 6 closing price
Ad is loading...

CFIMX vs FXAIX

Header iconCFIMX vs FXAIX Comparison
Open Charts CFIMX vs FXAIXBanner chart's image
Clipper
Price$138.05
Change-$0.00 (-0.00%)
VolumeN/A
CapitalizationN/A
Fidelity 500 Index
Price$188.25
Change-$0.00 (-0.00%)
VolumeN/A
CapitalizationN/A
View a ticker or compare two or three
CFIMX vs FXAIX Comparison Chart
Loading...
VS
CFIMX vs. FXAIX commentary
Sep 17, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CFIMX is a StrongBuy and FXAIX is a Buy.

FUNDAMENTALS
Fundamentals
FXAIX has more cash in the bank: 585B vs. CFIMX (1.12B). FXAIX pays higher dividends than CFIMX: FXAIX (1.31) vs CFIMX (0.84). CFIMX was incepted earlier than FXAIX: CFIMX (41 years) vs FXAIX (13 years). CFIMX is a more actively managed with annual turnover of: 8.00 vs. FXAIX (3.00). FXAIX has a lower initial minimum investment than CFIMX: FXAIX (0) vs CFIMX (2500). FXAIX annual gain was more profitable for investors over the last year : 28.44 vs. CFIMX (15.97). FXAIX return over 5 years is better than : 100.74 vs. CFIMX (26.45).
CFIMXFXAIXCFIMX / FXAIX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence41 years13 years-
Gain YTD9.54919.29249%
Front LoadN/AN/A-
Min. Initial Investment25000-
Min. Initial Investment IRAN/AN/A-
Net Assets1.12B585B0%
Annual Yield % from dividends0.841.3164%
Returns for 1 year15.9728.4456%
Returns for 3 years-2.2633.11-7%
Returns for 5 years26.45100.7426%
Returns for 10 years49.28204.7524%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
PRK172.562.56
+1.51%
Park National Corp
SEIC67.480.66
+0.99%
SEI Investments Company
MPU1.260.01
+0.80%
Mega Matrix Corp
ASNS1.66-0.03
-1.78%
Actelis Networks
APLT4.69-0.20
-4.09%
Applied Therapeutics